Investors have grown more cautious about putting their money into the inherently unpredictable drug development industry.
Even though the growth of Massachusetts' life sciences industry has slowed down and faces looming federal funding challenges, the sector is still expected to add thousands of jobs over the next decade ...
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record ...
The city is holding off its search for a developer and anchor tenant for its $1.6 billion life sciences campus in Kips Bay as ...
Shapiro said these proposed investments could spur additional private venture capital investment. Gov. Josh Shapiro came to Pittsburgh Tuesday to promote his proposed $50 million investment in ...
LONDON, July 2 (Reuters) - The British government and the pharmaceutical industry remain far apart in a dispute over drug pricing that has delayed publication of a long-pending plan for the UK life ...
Massachusetts’ biotech workforce remained relatively stagnant last year, following several years of slowing growth, according to data released Tuesday by MassBioEd, an industry group focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback